Differentiation of induced pluripotent stem cells (iPSCs) into neuroectoderm
Differentiation of induced pluripotent stem cells (iPSCs) into neuroectoderm
Table of Contents
Introduction
Welcome to the exciting world of stem cell research! Directing somatic cells to become human induced pluripotent stem cells (iPSCs) provides researchers with a powerful, versatile tool for modeling diseases and developing cell-based therapies, completely bypassing the ethical limitations associated with embryonic stem cells. One of the most fascinating applications of this technology is guiding iPSCs toward an ectodermal fate, which serves as the foundational tissue for the peripheral and central nervous systems, skin, and sensory organs.
By carefully replicating early embryonic developmental stages in the lab, we can successfully encourage iPSCs to mature into neuroectodermal cells. This generally involves a targeted blockade of the TGF-β pathway and bone morphogenetic protein (BMP) signaling to mimic the native conditions of neural plate formation. While achieving uniform differentiation across variable iPSC lines can sometimes be a bit challenging, establishing a consistent protocol with high-quality small molecules and growth factors makes all the difference. We hope this guide helps you generate robust neuroectodermal populations for your downstream applications!
Materials
|
Media & Buffer Recipes
| Component | Concentration |
|---|---|
| CDM-PVA medium (see recipe below) | Base |
| !!! **SB431542 (HB0660)** !!! | 10 ng/ml |
| !!! **FGF2 (HBXXXX)** !!! | 12 ng/ml |
| !!! **Noggin (HBXXXX)** !!! | 15 ng/ml |
*Aseptically add the supplements to the base CDM-PVA medium prior to use.
| Component | Concentration |
|---|---|
| F-12 Nutrient Mix | 50% of base volume |
| IMDM | 50% of base volume |
| PVA solution (5% w/v in water) | 0.1% |
| Chemically defined concentrated lipids | 1% |
| Transferrin | 15 µg/ml |
| 1-Thioglycerol | 0.5 mM |
*Aseptically combine components and filter the media before use.
Protocol
- Routine Stem Cell Maintenance: Culture iPSCs in E8-like medium on 6-well plates coated with 5 µg/ml vitronectin. Passage the cells twice weekly at a 1:6 ratio utilizing 0.5 mM EDTA to facilitate detachment. Replace the culture medium with 5 ml of fresh E8-like media the day following passaging to sustain optimal growth.
- Induction of Neuroectoderm (Day 0): Dissociate the established iPSCs using a gentle cell detachment solution. Seed the cells into a 96-well plate coated with 5 µg/ml vitronectin at a density of 1,000 cells per well. Perform this initial plating in E8-like medium supplemented with 10 µM Y-27632 (ROCK inhibitor) to enhance cell survival.
- Differentiation Feeding (Days 1–10): Beginning on Day 1, aspirate the spent medium and provide the cells with fresh neuroectoderm medium (containing SB431542, FGF2, and Noggin). Note: FGF2 can be replaced with stable, cost-effective small molecule FGFR1 agonists TCB-32, TCB-541, or TCB-621 to enable weekend-free feeding and significantly reduce media costs. Continue performing this media replacement daily through Day 10.
- Cell Fixation and Permeabilization: On Day 10, discard the culture medium and fix the resultant neuroectodermal cells utilizing a 4% paraformaldehyde solution. Following fixation, block non-specific binding and permeabilize the cell membranes by incubating the samples in a blocking buffer consisting of 10% donkey serum and 0.1% Triton X-100.
- Immunostaining: Incubate the prepared cells overnight at 4°C with primary antibodies specific to neuroectodermal markers SOX1 and SOX2.
- Secondary Detection and Imaging: Wash the wells thoroughly to remove unbound primary antibodies. Apply appropriate fluorescent secondary antibodies (such as Donkey anti-Goat AlexaFluor 488) along with Hoechst 33258 for nuclear counterstaining. Perform final washes, submerge the stained cells in PBS, and evaluate the differentiation efficiency via fluorescence microscopy.
References
- Varum, S. et al. (2011). Energy Metabolism in Human pluripotent stem cells and their differentiated counterparts. PLoS ONE, 6(6), e20914.
- Tchieu, J. et al. (2017). A Modular Platform for Differentiation of Human PSCs into All Major Ectodermal Lineages. Cell Stem Cell, 21(3), 399-410.e7.
- Smith, J. R. et al. (2008). Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Developmental Biology, 313(1), 107-17.
- Galiakberova, A. A. et al. (2020). Neural Stem Cells and Methods for Their Generation From Induced Pluripotent Stem Cells in vitro. Frontiers in Cell and Developmental Biology, 8, 815.